Medivation tipped for acquisition by Sanofi or AstraZeneca
Medivation (Nasdaq:MDVN), the San Francisco-based biopharmaceutical company, is believed to be a potential takeover target for European drugs groups, The Daily Mail reported.
France-based Sanofi (EPA:SAN), UK-headquartered AstraZeneca (LON:AZN) and Roche (SWX:RO) of Switzerland are tipped as prospective acquirers, the report said, citing unattributed market speculation.
Daily Mail